相关实验视频

Updated: Sep 9, 2025

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

一种新的活体减弱疫苗菌株的发展和生物特性

Xue Song¹, Xiumei Ren¹, Yang Song¹

¹Beijing Minhai Biotechnology Co., Ltd., Beijing 102609, China.

|August 28, 2025

概括

一种新的活体减弱型疫苗菌株MuV-365被开发出来,并证明了其安全性和有效性. 在临床前研究中,这种有前途的疫苗候选药物显示出基因稳定性和强烈的免疫性.

科学领域:

病毒学
疫苗学
免疫学

背景情况:

开发新型疫苗对于控制传染病至关重要.
仍然是一个公共卫生问题,需要有效的疫苗接种策略.

研究的目的:

开发和描述一种新的活体减弱型疫苗菌株 (MuV-365).
评估MuV-365菌株和含有它的麻疹-疹-红疹 (MMR) 疫苗的安全性,免疫性和有效性.

主要方法:

对候选MuV-365菌株进行斑块净化,放大和测序.
对神经毒性和一般疫苗安全性的临床前安全性评估.
通过抗体定位对小鼠和 rhesus 进行免疫性和疗效评估.

主要成果:

MuV-365菌株已成功开发,并与已确定的菌株呈现出高度的序列相似性.
没有观察到MuV-365的神经毒性;含有它的MMR疫苗显示出良好的安全性.
MuV-365表现出与小鼠现有菌株相比的或更高的免疫性,并在 rhesus 子中诱导强烈的抗体反应.

结论:

MuV-365菌株在遗传上是稳定的,安全的,并且具有免疫性.
这种新型疫苗候选药物具有有效预防的潜力.

关键词:

免疫性麻疹疹红疹疫苗疹病毒-365 安全性

更多相关视频

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

相关概念视频

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Vaccinations

Vaccinations